Why is Ajanta Pharma falling/rising?

As of 01-Aug, Ajanta Pharma Ltd. is experiencing a decline in its stock price, currently at 2,690.00, reflecting a decrease of 50.0 points or 1.82%. The stock has been on a downward trend, having fallen for the last three days, resulting in a total decline of 4.85% during this period. Despite outperforming its sector by 1.34% today, the stock's performance over the past week shows a loss of 3.41%, while it has gained 7.39% over the past month. The company has demonstrated high management efficiency with a return on equity (ROE) of 22.06% and a low debt-to-equity ratio, which are positive indicators. Additionally, it reported its highest net sales and profit before depreciation, interest, and taxes (PBDIT) in the last quarter, contributing to its overall stability.
Broader Market Context: In comparison to the benchmark Sensex, which has decreased by 1.06% over the past week, Ajanta Pharma's short-term performance is notably worse, indicating a relative underperformance. The pharmaceuticals and drugs sector has also faced a decline of 3.27%, reflecting broader challenges in the market. However, the stock's liquidity remains adequate, with a delivery volume increase of 5.72% against the five-day average, suggesting some investor interest despite the recent price drop. The high institutional holdings at 26.36% may provide some support, as these investors typically have the resources to analyze the company's fundamentals more effectively than retail investors.